JPM Healthcare Conference 2025

Join The Nemetz Group at JPM 2025 in San Francisco CA January 13-16, 2025

January 13–16, 2025 • San Francisco, CA, USA

Join The NemetzGroup during the 43rd JPM Healthcare Conference 2025

This premier conference is the largest and most informative healthcare investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators, and investment community members.

Biopharma leaders rely on The NemetzGroup’s deep in-house commercialization and medical affairs experience to craft a holistic approach to knowing what to do, when, and why. In the ever-changing biopharma landscape, the flexible, custom support of The NemetzGroup keeps companies moving forward with confidence in their mission to serve patients.

Connect with Marnie Hoolahan and Ray Mankoski, MD, PhD while you’re in San Francisco. 


We're looking forward to 2024 BIO International Convention in San Diego! See you there June 4–6, 2024

2024 BIO International Convention

We're looking forward to 2024 BIO International Convention in San Diego! See you there June 4–6, 2024

Attending June 4–6, 2024

We’re looking forward to the 2024 BIO International Convention in San Diego!

The experienced consultants at The NemetzGroup act as a seamless extension of biopharma teams, turning strategies into actionable plans and enabling execution through hands-on support. Connect with Marnie Hoolahan and Kristin Owens while you’re in San Diego to learn more about how The NemetzGroup can provide flexible, custom commercialization support to keep your company moving forward with confidence in your mission to serve patients.


We're looking forward to 2024 ASCO Annual Meeting in Chicago! See you there May 31–June 2, 2024

2024 ASCO Annual Meeting

We're looking forward to 2024 ASCO Annual Meeting in Chicago! See you there May 31–June 2, 2024

Attending May 31–June 2, 2024

We’re looking forward to the 2024 ASCO Annual Meeting!

Biopharma leaders rely on The NemetzGroup’s deep in-house commercialization and medical affairs experience to craft a holistic approach to knowing what to do, when, and why. In the ever-changing biopharma landscape, the flexible, custom support of The NemetzGroup keeps companies moving forward with confidence in their mission to serve patients. Connect with Senior Consultant Ray Mankoski, MD, PhD while you’re in Chicago to learn more about how The NemetzGroup can help bring your cancer drug to life.